Quest Diagnostics gaps down, spikes lower, after earnings The stock was last down over 6.5% which is off the lows of the session. The company reported earnings of $1.01 per share versus consensus of $1.02 for its Q4. It is guidance which is taking the shares down, which was reduced to a range of $4.35 to $4.55 for its fiscal year 2013 versus consensus of $4.81. At the current price of $57.66, support is at $57.11. a recent pivot low on the daily chart. Resistance is at $58, today's opening price.
Quest to acquire MemorialCare's laboratory outreach service business Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business. The transaction is expected to be neutral to earnings in 2015. Quest and MemorialCare Health System expect to complete the acquisition in August. Financial terms were not disclosed.